Live News NEWS FLASH L impact Sep 28, 2026, 06:25 AM UTC Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment Oryzon Genomics SA BME:ORY ORY SquawkNews Newsroom